NO20082459L - Nye prosesser for fremstilling av piperazinyl og diazapanylbenzamidderivater - Google Patents
Nye prosesser for fremstilling av piperazinyl og diazapanylbenzamidderivaterInfo
- Publication number
- NO20082459L NO20082459L NO20082459A NO20082459A NO20082459L NO 20082459 L NO20082459 L NO 20082459L NO 20082459 A NO20082459 A NO 20082459A NO 20082459 A NO20082459 A NO 20082459A NO 20082459 L NO20082459 L NO 20082459L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- piperazinyl
- diazapanyl
- new processes
- benzamide derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73194105P | 2005-10-31 | 2005-10-31 | |
| PCT/US2006/041859 WO2007053427A2 (en) | 2005-10-31 | 2006-10-26 | Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20082459L true NO20082459L (no) | 2008-07-22 |
Family
ID=37766699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20082459A NO20082459L (no) | 2005-10-31 | 2008-05-30 | Nye prosesser for fremstilling av piperazinyl og diazapanylbenzamidderivater |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US7728129B2 (pt) |
| EP (2) | EP2404911A1 (pt) |
| JP (1) | JP2009513702A (pt) |
| KR (1) | KR20080067365A (pt) |
| CN (1) | CN101389617A (pt) |
| AR (1) | AR056750A1 (pt) |
| AU (1) | AU2006309077A1 (pt) |
| BR (1) | BRPI0617947A2 (pt) |
| CA (1) | CA2628210A1 (pt) |
| CR (1) | CR10037A (pt) |
| EA (2) | EA201001799A1 (pt) |
| EC (1) | ECSP088416A (pt) |
| IL (1) | IL190963A0 (pt) |
| NO (1) | NO20082459L (pt) |
| NZ (1) | NZ567357A (pt) |
| SV (1) | SV2009002893A (pt) |
| TW (1) | TW200736239A (pt) |
| WO (1) | WO2007053427A2 (pt) |
| ZA (1) | ZA200804732B (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0324159D0 (en) | 2003-10-15 | 2003-11-19 | Glaxo Group Ltd | Novel compounds |
| SI2121636T1 (sl) * | 2006-12-14 | 2017-06-30 | Janssen Pharmaceutica N.V. | Postopek za pripravo derivatov piperazinila in diazepanil benzamida |
| US8288389B2 (en) | 2007-09-06 | 2012-10-16 | Glaxo Group Limited | Piperazine derivative having affinity for the histamine H3 receptor |
| CN111610246B (zh) * | 2019-02-25 | 2023-05-12 | 中国科学院上海有机化学研究所 | 用于质谱检测的羧基衍生化试剂组合物及其用途 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9807354D0 (en) * | 1998-04-07 | 1998-06-03 | Glaxo Group Ltd | Antiviral compound |
| US7141593B1 (en) * | 1999-06-04 | 2006-11-28 | Abbott Laboratories | Pharmaceutical formulations |
| SK5202000A3 (en) * | 2000-04-07 | 2001-12-03 | Slovakofarma As | Method for the preparation of (e)-n-(6,6-dimethyl-2-hepten-4- inyl)-n-methyl-1-naphthalenemethylamine (terbinaphin) |
| WO2002002514A1 (de) | 2000-07-05 | 2002-01-10 | Basf Aktiengesellschaft | Verfahren zur herstellung von trioximderivaten |
| ES2258142T3 (es) * | 2001-05-22 | 2006-08-16 | Pfizer Products Inc. | Nueva forma cristalina. |
| US6548670B1 (en) | 2001-07-19 | 2003-04-15 | Air Products And Chemicals, Inc. | Methods for preparing 5- and 6-benzyl-functionalized quinoxalines |
| US6821502B2 (en) * | 2002-06-12 | 2004-11-23 | Chevron U.S.A. Inc. | Method of making aluminum-containing zeolite with IFR structure |
| EP1558595B1 (en) * | 2002-10-23 | 2009-11-25 | Janssen Pharmaceutica N.V. | Piperazinyl and diazapanyl benzamides and benzthioamides |
| EP1660472A1 (en) * | 2003-08-27 | 2006-05-31 | Janssen Pharmaceutica N.V. | Aryl piperidine amides |
| AR047541A1 (es) * | 2004-02-13 | 2006-01-25 | Sandoz Ag | Fosfato de 5-[[4-[2-metil-2-piridinil-amino-etoxi]fenil]metil]-2,4 tiazolidinadiona (rosiglitazona) y sus formas polimorficas |
| US7351833B2 (en) * | 2004-07-23 | 2008-04-01 | Abbott Laboratories | (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate |
| US8436176B2 (en) * | 2004-12-30 | 2013-05-07 | Medicis Pharmaceutical Corporation | Process for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine |
| UA91546C2 (uk) * | 2005-05-03 | 2010-08-10 | Бьорінгер Інгельхайм Інтернаціональ Гмбх | КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ |
| MY152185A (en) * | 2005-06-10 | 2014-08-29 | Novartis Ag | Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation |
| BRPI0615259A2 (pt) * | 2005-08-29 | 2011-05-17 | Sanofi Aventis Us Llc | forma cristalina de um derivado de piridazino[4,5-b] indol |
| CN101687905A (zh) * | 2005-09-13 | 2010-03-31 | 西科尔公司 | 纯罗库溴铵 |
| MX2009003405A (es) * | 2006-09-28 | 2009-04-09 | Merck & Co Inc | Composiciones farmaceuticas de inhibidores de la histona desacetilasa y compuestos quelantes de metal, y complejos de quelato de metal-inhibidor de histona desacetilasa. |
| US7837978B2 (en) * | 2006-10-13 | 2010-11-23 | Chevron U.S.A. Inc. | Process for preparing aluminum-containing molecular sieve SSZ-26 |
| PE20081506A1 (es) * | 2006-12-12 | 2008-12-09 | Infinity Discovery Inc | Formulaciones de ansamicina |
| AU2008253803A1 (en) * | 2007-05-22 | 2008-11-27 | Ultimorphix Technolgies B.V. | Tenofovir disoproxil hemi-fumaric acid Co-crystal |
| TW200944520A (en) * | 2008-01-29 | 2009-11-01 | Glaxo Group Ltd | Spiro compounds as NPY Y5 receptor antagonists |
-
2006
- 2006-10-26 EP EP11183817A patent/EP2404911A1/en not_active Withdrawn
- 2006-10-26 EA EA201001799A patent/EA201001799A1/ru unknown
- 2006-10-26 CN CNA2006800406803A patent/CN101389617A/zh active Pending
- 2006-10-26 EA EA200801239A patent/EA014905B1/ru unknown
- 2006-10-26 JP JP2008538930A patent/JP2009513702A/ja active Pending
- 2006-10-26 WO PCT/US2006/041859 patent/WO2007053427A2/en not_active Ceased
- 2006-10-26 AU AU2006309077A patent/AU2006309077A1/en not_active Abandoned
- 2006-10-26 BR BRPI0617947-9A patent/BRPI0617947A2/pt not_active IP Right Cessation
- 2006-10-26 CA CA002628210A patent/CA2628210A1/en not_active Abandoned
- 2006-10-26 NZ NZ567357A patent/NZ567357A/en not_active IP Right Cessation
- 2006-10-26 KR KR1020087013062A patent/KR20080067365A/ko not_active Ceased
- 2006-10-26 US US11/553,158 patent/US7728129B2/en active Active
- 2006-10-26 EP EP06826786A patent/EP1951700A2/en not_active Withdrawn
- 2006-10-30 TW TW095139961A patent/TW200736239A/zh unknown
- 2006-10-31 AR ARP060104773A patent/AR056750A1/es not_active Application Discontinuation
-
2008
- 2008-04-17 IL IL190963A patent/IL190963A0/en unknown
- 2008-04-30 SV SV2008002893A patent/SV2009002893A/es not_active Application Discontinuation
- 2008-04-30 EC EC2008008416A patent/ECSP088416A/es unknown
- 2008-05-30 NO NO20082459A patent/NO20082459L/no not_active Application Discontinuation
- 2008-05-30 CR CR10037A patent/CR10037A/es not_active Application Discontinuation
- 2008-05-30 ZA ZA200804732A patent/ZA200804732B/xx unknown
-
2010
- 2010-04-19 US US12/762,912 patent/US20100197689A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| TW200736239A (en) | 2007-10-01 |
| CR10037A (es) | 2008-11-24 |
| WO2007053427A2 (en) | 2007-05-10 |
| WO2007053427A3 (en) | 2007-07-12 |
| IL190963A0 (en) | 2008-12-29 |
| ZA200804732B (en) | 2009-11-25 |
| US7728129B2 (en) | 2010-06-01 |
| US20100197689A1 (en) | 2010-08-05 |
| EP1951700A2 (en) | 2008-08-06 |
| EP2404911A1 (en) | 2012-01-11 |
| BRPI0617947A2 (pt) | 2011-08-09 |
| ECSP088416A (es) | 2008-05-30 |
| CA2628210A1 (en) | 2007-05-10 |
| JP2009513702A (ja) | 2009-04-02 |
| EA200801239A1 (ru) | 2008-08-29 |
| AR056750A1 (es) | 2007-10-24 |
| AU2006309077A1 (en) | 2007-05-10 |
| EA201001799A1 (ru) | 2011-06-30 |
| SV2009002893A (es) | 2009-06-18 |
| EA014905B1 (ru) | 2011-02-28 |
| KR20080067365A (ko) | 2008-07-18 |
| CN101389617A (zh) | 2009-03-18 |
| NZ567357A (en) | 2011-05-27 |
| US20070197508A1 (en) | 2007-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200970583A1 (ru) | Способ получения пиперазиниловых и диазепаниловых производных бензамида | |
| NO20071343L (no) | Substituerte fenylaminotiazoler og anvendelse derav | |
| MY151246A (en) | Benzofuranyl derivatives | |
| NO20076344L (no) | Piperazin-piperidin-antagonister og agonister av 5-HT1A-reseptoren | |
| PA8784001A1 (es) | Oxazolidinonas sustituidas y su uso | |
| NO20075406L (no) | Pyrimidindionerivater som prokineticin-2-reseprorantagonister | |
| EA200901042A1 (ru) | Производные 1-бензенсульфонил-1h-индола в качестве ингибиторов активности ccr9 | |
| NO20080445L (no) | Nye azetidinderivater som neurokininreseptorantagonister for behandling av gastrointestinale sykdommer | |
| NI200700032A (es) | Derivados arilsulfonilestilbeno para tratamiento de insomnio y afecciones relacionadas | |
| MY153719A (en) | Prokineticin 1 receptor antagonists | |
| CR10036A (es) | Procedimientos para la preparación de derivados de ciclopropilamida | |
| NO20082459L (no) | Nye prosesser for fremstilling av piperazinyl og diazapanylbenzamidderivater | |
| ATE481972T1 (de) | Chinazolinon-derivate als vanilloid-antagonisten | |
| CY1110087T1 (el) | Μεθοδοι παρασκευης ενωσεων που περιεχουν πυρραζολιο | |
| ATE524463T1 (de) | 4-chromenonyl-1,4-dihydropyridincarbonitrile und ihre verwendung | |
| ATE489383T1 (de) | Isoindolin-1-on-, isoindolin-3-on- und isoindolin-1,3-dion-derivate und ihre verwendung | |
| EA200602081A1 (ru) | Пиридиновые производные алкилоксиндолов в качестве агентов, активных в отношении рецептора 5-нт7 | |
| DK1945206T3 (da) | Indolderivater som histamin 3-receptorinhibitorer til behandling af kognitive forstyrrelser og søvnforstyrrelser, obesitas og andre CNS-forstyrrelser | |
| EA200602084A1 (ru) | Пиперазиновые производные алкилоксиндолов | |
| NO20065697L (no) | Piperazinderivater av alkyloksindoler. | |
| EA200701877A1 (ru) | Производные замещённых пиридинов |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |